351 related articles for article (PubMed ID: 11085894)
1. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
3. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging.
Ishiwata K; Ogi N; Hayakawa N; Oda K; Nagaoka T; Toyama H; Suzuki F; Endo K; Tanaka A; Senda M
Ann Nucl Med; 2002 Nov; 16(7):467-75. PubMed ID: 12508837
[TBL] [Abstract][Full Text] [Related]
5. The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
Besret L; Page KJ; Dunnett SB
Brain Res; 2000 Jan; 853(1):125-35. PubMed ID: 10627316
[TBL] [Abstract][Full Text] [Related]
6. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
7. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL
J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment.
Levivier M; Przedborski S
Neurol Res; 1998 Jan; 20(1):46-56. PubMed ID: 9471103
[TBL] [Abstract][Full Text] [Related]
9. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Wei H; Qin ZH; Senatorov VV; Wei W; Wang Y; Qian Y; Chuang DM
Neuroscience; 2001; 106(3):603-12. PubMed ID: 11591460
[TBL] [Abstract][Full Text] [Related]
10. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
[TBL] [Abstract][Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
12. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
Svenningsson P; Gunne L; Andren PE
Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
[TBL] [Abstract][Full Text] [Related]
13. Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia.
Van Kampen JM; Stoessl AJ
Neuroscience; 2000; 98(1):61-7. PubMed ID: 10858612
[TBL] [Abstract][Full Text] [Related]
14. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
16. Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography.
Araki T; Kato H; Shuto K; Fujiwara T; Itoyama Y
J Neurol Sci; 1997 May; 148(2):131-7. PubMed ID: 9129108
[TBL] [Abstract][Full Text] [Related]
17. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK
Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
[TBL] [Abstract][Full Text] [Related]
18. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA.
Venero JL; Beck KD; Hefti F
Neuroscience; 1994 Jul; 61(2):257-68. PubMed ID: 7969907
[TBL] [Abstract][Full Text] [Related]
19. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
[TBL] [Abstract][Full Text] [Related]
20. Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.
MacGibbon GA; Hamilton LC; Crocker SF; Costain WJ; Murphy KM; Robertson HA; Denovan-Wright EM
J Neurosci Res; 2002 Feb; 67(3):372-8. PubMed ID: 11813242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
